ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/·4

Jan 6, 2:24 PM ET

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ 4

4 · ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ · Filed Jan 6, 2010

Insider Transaction Report

Form 4
Period: 2010-01-04
ROUSE JAMES E
DirectorPresident & CEO
Transactions
  • Award

    stock option

    2010-01-04+7,50017,000 total
    Exercise: $3.41Exp: 2016-01-04common stock (7,500 underlying)
Footnotes (2)
  • [F1]The option holder may exercise purchase rights for 1,500 shares on or after 1/4/2011, and 1,500 each on or after anniversary date each year until 7,500 are exercised.
  • [F2]The consideration for the options is the option holder's future service to the company.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4